Luteal phase dose–response relationships of the antiprogestin CDB‐2914 in normally cycling women*

Author：  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.18, Iss.9, 2003-09, pp. : 1820-1827

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contraception. A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women

By Stratton Pamela  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1092-1099

Oxford University Press

Access to resources Recommend Favorite

Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

By Takeuchi Tsutomu  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 226-235

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate

By Takeuchi Tsutomu  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 236-236

Springer Publishing Company

Access to resources Recommend Favorite

Contraception. CDB-2914: Anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits

By Hild Sheri Ann  

Human Reproduction, Vol. 15, Iss. 4, 2000-04 ,pp. : 822-829

Oxford University Press

Access to resources Recommend Favorite

Contraception. Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration

By Larner J.M.   Reel J.R.  

Human Reproduction, Vol. 15, Iss. 5, 2000-05 ,pp. : 1100-1106

Oxford University Press

Access to resources Recommend Favorite